Atlas Trials

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

Clinical trial NCT04225858 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04225858
Sponsor
The Netherlands Cancer Institute
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerTriple Negative Breast CancerHER2-positive Breast CancerSentinel Lymph Node
Start date
2020-01-01
Primary completion
2025-01-01
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.